Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

The health care community has redefined the requirements for clinical obesity, noting BMI shouldn’t be the sole barometer of ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...